Designing psycho-oncology randomised trials and cluster randomised trials: Variance components and intra-cluster correlation of commonly used psychosocial measures

Psycho-Oncology

Volumn 22, Issue 8, 2013, Pages 1738-1747

  Bell, Melanie L ^a   McKenzie, Joanne E ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

cancer; design; ICC; longitudinal; oncology; statistical methodology

Indexed keywords

ARTICLE; BECK DEPRESSION INVENTORY; BREAST CANCER; CANCER PATIENT; COLORECTAL CANCER; FAMILIAL CANCER; FUNCTIONAL ASSESSMENT; GENERAL HEALTH QUESTIONNAIRE; HOSPITAL ANXIETY AND DEPRESSION SCALE; IMPACT OF EVENTS SCALE; INSOMNIA SEVERITY INDEX; INTRA CLUSTER CORRELATION; KNOWLEDGE; LONGITUDINAL STUDY; LUNG CANCER; OVARY CANCER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEXUALITY; SOCIAL PSYCHOLOGY; STATISTICAL ANALYSIS; VARIANCE;

CANCER; DESIGN; ICC; LONGITUDINAL; ONCOLOGY; STATISTICAL METHODOLOGY;

ANALYSIS OF VARIANCE; CLUSTER ANALYSIS; HEALTH SERVICES RESEARCH; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SAMPLE SIZE; SAMPLING STUDIES;

EID: 84880699643     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.3205     Document Type: Article

References (67)

1. Donner A, Klar N,. Design and analysis of cluster randomization trials in health research. Arnold Publishing: London, UK, 2000.
2. Donner A, Klar N,. Cluster randomization trials. Stat Methods Med Res 2000; 9 (2): 79-80.
3. Hayes RJ, Moulton LH,. Cluster Randomised Trials. Chapman & Hall/CRC: Boca Raton, Fl, 2009.
4. Campbell MK, Elbourne DR, Altman DG,. CONSORT statement: extension to cluster randomised trials. Br Med J, 2004; 328 (7441): 702-708.
5. Torgerson DJ,. Contamination in trials: is cluster randomisation the answer? Br Med J, 2001; 322 (7282): 355-357.
6. Eldridge SM, Ukoumunne OC, Carlin JB,. The intra-cluster correlation coefficient in cluster ranomized trials: a review of definitions. Int Stat Rev 2009; 77: 378-394.
7. Murray DM, Varnell SP, Blitstein JL,. Design and analysis of group-randomized trials: a review of recent methodological developments. Am J Public Health 2004; 94 (3): 423-432.
8. Campbell MJ,. Cluster randomized trials in general (family) practice research. Stat Methods Med Res 2000; 9 (2): 81-94.
9. Campbell MK, Grimshaw JM, Elbourne DR,. Intracluster correlation coefficients in cluster randomized trials: empirical insights into how should they be reported. BMC Med Res Methodol 2004; 4: 1-5.
10. Simpson JM, Klar N, Donner A,. Accounting for cluster randomization: a review of primary prevention trials, 1990 through 1993. Am J Public Health 1995; 85 (10): 1378-1383.
11. Braeken AP, Lechner L, van Gils FC, Houben RM, Eekers D, Ambergen T, Kempen GI,. The effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in cancer patients treated with radiotherapy: design of a cluster randomised controlled trial. BMC Cancer, 2009; 9: 1201-1214.
12. Moorey S, Cort E, Kapari M, et al,. A cluster randomized controlled trial of cognitive behaviour therapy for common mental disorders in patients with advanced cancer. Psychol Med 2009; 39 (5): 713-723.
13. Donner A, Klar N,. Pitfalls of and controversies in cluster randomization trials. Am J Public Health 2004; 94 (3): 416-422.
14. Vickers AJ, Altman DG,. Analysing controlled trials with baseline and follow up measurements. Br Med J 2001; 323 (7321): 1123-1124.
15. Frison L, Pocock SJ,. Repeated measures in clinical trials: analysis using mean summary statistics and its implications for design. Stat Med 1992; 11 (13): 1685-1704.
16. Klar N, Darlington G,. Methods for modelling change in cluster randomization trials. Stat Med 2004; 23 (15): 2341-2357.
17. Wei L, Zhang J,. Analysis of data with imbalance in the baseline outcome variable for randomized clinical trials. Drug Inf J 2001; 35 (4): 1201-1214.
18. Adams G, Gulliford MC, Ukoumunne OC, Eldridge S, Chinn S, Campbell MJ,. Patterns of intra-cluster correlation from primary care research to inform study design and analysis. J Clin Epidemiol, 2004; 57 (8): 785-794.
19. Murray DM, Phillips GA, Birnbaum Birnbaum, Lytle Lytle,. Intraclass correlation for measures from a middle school nutrition intervention study: estimates, correlates, and applications. Health Educ Behav, 2001. 28 (6): p. 666-679.
20. Murray DM, Blitstein JL,. Methods to reduce the impact of intraclass correlation in group-randomized trials. Eval Rev 2003; 27 (1): 79-103.
21. Klar N, Donner A,. The merits of matching in community intervention trials: a cautionary tale. Stat Med 1997; 16 (15): 1753-1764.
22. Donner A,. Some aspects of the design and analysis of cluster randomization trials. J R Stat Soc Ser C Appl Stat 1998; 47 (1): 95-113.
23. Donner A,. Sample size requirements for stratified cluster randomization designs. Stat Med 1992; 11 (6): 743-750.
24. Taljaard M, Donner A, Klar N,. Accounting for expected attrition in the planning of community intervention trials. Stat Med 2007; 26 (13): 2615-2628.
25. Guittet L, Ravaud P, Giraudeau B,. Planning a cluster randomized trial with unequal cluster sizes: practical issues involving continuous outcomes. BMC Med Res Methodol 2006; 6 (17): 1-15.
26. van Breukelen GJP, Candel MJJM, Berger MPF,. Relative efficiency of unequal versus equal cluster sizes in cluster randomized and multicentre trials. Stat Med 2007; 26 (13): 2589-2603.
27. Eldridge SM, Ashby D, Kerry S,. Sample size for cluster randomized trials: effect of coefficient of variation of cluster size and analysis method. Int J Epidemiol 2006; 35 (5): 1292-1300.
28. Hemming K, et al,. Sample size calculations for cluster randomised controlled trials with a fixed number of clusters. BMC Med Res Methodol 2011; 11 (102): 1-11.
29. Campbell M, Grimshaw G, Steen N,. Sample size calculations for cluster randomised trials. J Health Serv Res Policy 2000; 5 (1): 12-16.
30. Murray DM, Pals SL, Blitstein JL, Alfano CM, Lehman J,. Design and analysis of group-randomized trials in cancer: a review of current practices. J Natl Cancer Inst 2008; 100 (7): 483-491.
31. Crespi CM, Maxwell AE, Wu S,. Cluster randomized trials of cancer screening interventions: are appropriate statistical methods being used? Contemp Clin Trials 2011; 32 (4): 477-484.
32. Price MA, Zachariae R, Butow PN, et al,. Prevalence and predictors of insomnia in women with invasive ovarian cancer: anxiety a major factor. Eur J Cancer 2009; 45 (18): 3262-3270.
33. Peate M, Meiser B, Friedlander M, et al,. It's now or never: fertility-related knowledge, decision-making preferences, and treatment intentions in young women with brieast cancer-an Australian fertility decision aid collaborative group study. J Clin Oncol 2011; 29 (13): 1670-1677.
34. Hayes S, Rye S, Battistutta D, et al,. Design and implementation of the Exercise for Health trial-a pragmatic exercise intervention for women with breast cancer. Contemp Clin Trials 2011; 32 (4): 577-585.
35. Butow P, Devine R, Boyer M, Pendlebury S, Jackson M, Tattersall M,. Cancer consultation preparation package: changing patients but not physicians is not enough. J Clin Oncol 2004; 22 (21): 4401-4409.
36. Brown RF, Butow PN, Dunn SM, Tattersall M,. Promoting patient participation and shortening cancer consultations: a randomised trial. Br J Cancer 2001; 85 (9): 1273-1279.
37. Schofield P, Lotfi-Jam K, Gough K, et al,. A nurse-led group consultation intervention to reduce psychological morbidity and unmet needs in men with prostate cancer during radiotherapy: a randomised controlled trial. In MASCC/ISOO International Symposium on Supportive Care in Cancer. New York City, USA, 2012.
38. Juraskova I, Bonner C, Bell ML, Sharpe l, Robertson R, Butow P,. Quantity versus quality: an exploration of the predictors of post-treatment sexual adjustment for women affected by early stage cervical and endometrial cancer. J Sex Med 2012.
39. Clayton JM, Butow PN, Tattersall M, et al,. Randomized controlled trial of a prompt list to help advanced cancer patients and their caregivers to ask questions about prognosis and end-of-life care. J Clin Oncol 2007; 25 (6): 715-723.
40. Wakefield CE, Meiser B, Homewood J, et al,. A randomized controlled trial of a decision aid for women considering genetic testing for breast and ovarian cancer risk. Breast Cancer Res Treat 2008; 107 (2): 289-301.
41. Wakefield CE, Meiser B, Homewood J, et al,. Randomized trial of a decision aid for individuals considering genetic testing for hereditary nonpolyposis colorectal cancer risk. Cancer, 2008. 113 (5): p. 956-965.
42. Wakefield CE, Meiser B, Homewood J, et al,. A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling. Psycho-Oncology 2008; 17 (8): 844-854.
43. Mulcare H, Schofield P, Kashima Y, Milgrom J, Wirth A, Bishop M, Wheeler G, et al,. Adjustment to cancer and the information needs of people with lung cancer. Psycho-Oncology 2010; 20 (5): 488-496.
44. Meiser B, Butow P, Friedlander M, et al,. Psychological impact of genetic testing in women from high-risk breast cancer families. Eur J Cancer 2002; 38 (15): 2025-2031.
45. Bernhard J, Butow P, Aldridge J, Ribi K, Juraskova I, Brown R,. An international randomized trial of skills training for oncologists concerning communication about standard treatment options and clinical trials with patients with early breast cancer. In The 11th World Congress of the International Psycho-Oncological Society (IPOS). Vienna, 2009.
46. Oguchi M, Jansen J, Butow P, Colagiuri B, Divine R, Dhillon H,. Measuring the impact of nurse cue-response behaviour on cancer patients' emotional cues. Patient Educ Couns 2011; 82 (2): 163-168.
47. Beck A, Steer R, Brown G,. Manual for Beck Depression Inventory-II 1996. Psych Corp: San Antonio, TX, 1996.
48. O'Connor AM,. Validation of a decisional conflict scale. Med Decis Making 1995; 15 (1): 25-30.
49. Brehaut JC, O'Connor AM, Wood TJ, et al,. Validation of a decision regret scale. Med Decis Making 2003; 23 (4): 281-292.
50. Derogatis LR, Melisaratos N,. The DSFI: a multidimensional measure of sexual functioning. J Sex Marital Ther 1979; 5 (3): 244-281.
51. Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC,. Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer 1998; 82 (10): 1904-1908.
52. Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG,. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000; 56 (6): 899-905.
53. Cella DF, Tulsky DS, Gray G, et al,. The functional assessment of cancer therapy scale: development and validation of the general measure. J Clin Oncol 1993; 11 (3): 570-579.
54. Goldberg DP, Williams P,. Manual of the General Health Questionnaire. NFER Publishing: Windsor, England, 1978.
55. Zigmond AS, Snaith RP,. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67 (6): 361-370.
56. Horowitz M, Wilner N, Alvarez W,. Impact of event scale: a measure of subjective stress. Psychosom Med 1979; 41 (3): 209-218.
57. Bastien CH, VallieÌres A, Morin CM,. Validation of the insomnia severity index as an outcome measure for insomnia research. Sleep Med 2001; 2 (4): 297-307.
58. Scheier MF, Carver CS, Bridges MW,. Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation Test. J Pers Soc Psychol 1994; 67 (6): 1063-1078.
59. Watson M, et al,. Development of a questionnaire measure of adjustment to cancer: the MAC scale. Psychol Med 1988; 18 (1): 203-209.
60. Watson M, Greer S, Young J, Inayat Q, Burgess C, Robertson B,. The Mini-MAC: further development of the Mental Adjustment to Cancer scale. J Psychosoc Oncol 1994; 12 (3): 33-46.
61. Mesters I, Van Den Borne B, De Boer M, Pruyn J,. Measuring information needs among cancer patients. Patient Educ Couns 2001; 43 (3): 253-262.
62. Fayers P, Aaronson N, Bjordal K, et al,. The EORTC QLQ-C30 Scoring Manual. European Organisation for Research and Treatment of Cancer: Brussels, 2001.
63. Buunk BP, Collins RL, Taylor SE, VanYperen NW, Dakof GA,. The affective consequences of social comparison: either direction has its ups and downs. J Pers Soc Psychol 1990; 59 (6): 1238-1249.
64. Bonevski B, Sanson-Fisher R, Girgis A, et al,. Evaluation of an instrument to assess the needs of patients with cancer. Cancer 2000; 88 (1): 217-225.
65. Broadhead WE, Gehlbach SH, de Gruy FV, Kaplan BH,. The Duke-UNC Functional Social Support Questionnaire. Measurement of social support in family medicine patients. Med Care 1988; 26 (7): 709-723.
66. Spielberger CD,. Manual for the State-trait Anxiety Inventory: STAI (Form Y). Consulting Psychologists Press: Palo Alto, CA, 1983.
67. Holmes-Rovner M, Kroll J, Schmitt N, et al,. Patient satisfaction with health care decisions: the satisfaction with decision scale. Med Decis Making 1996; 16 (1): 58-64.